Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coeli is a Swedish asset manager and investment firm rather than a life science, biotech, pharma, or healthcare operating company. Founded in 1994, the partner-owned group provides asset management, wealth management, private equity, real estate, and related financial services to high-net-worth individuals, family offices, companies, and institutions. The firm manages a range of public-market and alternative investment strategies, including equity, fixed income, hedge fund, real estate, and private equity products. While Coeli may invest in healthcare or biotech companies through its funds, it does not itself appear to develop therapeutics, diagnostics, or healthcare products and therefore is not a healthcare company in the sense implied by the request.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coeli.